Head-to-Head hair regrowth trial: can common drugs reverse severe baldness?
NCT ID NCT07406204
Summary
This study will compare two existing oral medications—tofacitinib and methotrexate—for treating severe forms of alopecia areata, an autoimmune condition causing significant hair loss. Seventy-eight adults with severe hair loss will take one of the medications for 12 weeks to see which helps more hair grow back. The main goal is to see which drug leads to better hair regrowth, measured by a standard scoring system.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALOPECIA AREATA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.